The Future of Patent Protection for Post-FDA-Approved Generics: A Look at the Federal Circuit’s Incongruous Interpretations of 35 U.S.C. § 271(e)(1)’s “Safe Harbor” Provision

Authors

Alexandra Bollman Robertson

Document Type

Article

Academic Year

5-1-2014

Recommended Citation

Robertson, Alexandra Bollman, "The Future of Patent Protection for Post-FDA-Approved Generics: A Look at the Federal Circuit’s Incongruous Interpretations of 35 U.S.C. § 271(e)(1)’s “Safe Harbor” Provision" (2014). Student Works. 555.
https://scholarship.shu.edu/student_scholarship/555